CARDIOXYL PHARMACEUTICALS
Cardioxyl Pharmaceuticals is a privately held, clinical stage biopharmaceutical company developing therapies for the treatment of cardiovascular disease, focusing on the discovery, development and commercialization of novel technologies for disease areas where current therapies don't exist, are ineffective or are inadequate. Cardioxyl has developed industry-leading expertise in the chemistry, biology and clinical applications of nitroxyl technology. The company's core nitroxyl platform has generated several pre-clinical and clinical candidates including the company's lead compound, CXL-1020, currently in clinical development for Acute Decompensated Heart Failure, the most common cause of hospitalization for patients older than 65 years of age.
CARDIOXYL PHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2005-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Website Url:
http://www.cardioxyl.com
Total Employee:
10001+
Status:
Active
Contact:
+119198698586
Email Addresses:
[email protected]
Total Funding:
66.5 M USD
Technology used in webpage:
SPF Google Font API Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS GStatic Google Static Content Google Maps API Level 3 Communications
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Aurora Funds
The Aurora Funds investment in Series B - Cardioxyl Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series B - Cardioxyl Pharmaceuticals
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Cardioxyl Pharmaceuticals
OrbiMed
OrbiMed investment in Series B - Cardioxyl Pharmaceuticals
The Aurora Funds
The Aurora Funds investment in Venture Round - Cardioxyl Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Cardioxyl Pharmaceuticals
The Aurora Funds
The Aurora Funds investment in Series A - Cardioxyl Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series A - Cardioxyl Pharmaceuticals
Official Site Inspections
http://www.cardioxyl.com
- Host name: 165.89.235.20
- IP address: 165.89.235.20
- Location: Trenton United States
- Latitude: 40.2187
- Longitude: -74.7404
- Metro Code: 504
- Timezone: America/New_York
- Postal: 08629
